Help us to stop bowel cancer

We've appointed a new Director of External Affairs

Gus will be joining Bowel Cancer UK from Monday 29 February, having spent the past nine months at Leonard Cheshire Disability as their Managing Director - Public Affairs and Engagement, looking after their policy, public affairs and campaigns teams.

Deborah Alsina, Chief Executive of Bowel Cancer UK, said: "We're delighted that Gus will be joining us.  His appointment comes at a highly opportune time as we announced recently an ambitious move to become the UK's leading bowel cancer research charity, dedicated to stopping bowel cancer."

"The major advances in saving lives from bowel cancer in the past 20 years have all come through research.  We already know many of the reasons why people continue to die of the disease.  Gus will play a key role in leading our expanded policy and research programme to address these issues specifically.  Through strategic investment in targeted research, we will deliver improvements in bowel cancer survival in our lifetime."

"Our research aims to increase the number of people surviving bowel cancer within five years of diagnosis from 50 per cent to 75 per cent by 2025."

Gus started his campaigning career working in two public affairs consultancies before moving to Mencap to be their Parliamentary Officer.

He joined Macmillan Cancer Support in 2005 where he spent nearly ten years building a highly-respected, multi-award winning public affairs department, eventually becoming their Head of Public Affairs.

Gus has led various successful campaigns during his career, including helping to secure two new cancer strategies and to end prescription charges for cancer patients.

Gus says: "The opportunity to become a director at a charity with the ambition of Bowel Cancer UK was too good to turn down.  We absolutely must improve bowel cancer survival rates and I'm incredibly excited about having the chance to roll up my sleeves and help."

Bowel cancer is the second biggest cancer killer in the UK. If diagnosed at its earliest stage, nine out of ten people will survive bowel cancer yet this drops to just eight per cent as the disease develops and spreads. This is why early diagnosis is so vital. Currently only 18 per cent are diagnosed at this early stage.